why choose us

First received: October 21, 2023

Clinical Trial: Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

Study Status: Completed

Recruit Status: RECRUITING

Condition: EBV Infection After Allogenic HSCT

Study Type: INTERVENTIONAL


Official Title: Multicenter, Open Label, Single-arm Exploratory Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

Brief Summary: This is a multi-center, single arm, open-label, phase I study to determine the safety and effectiveness of EBV-TCR-T cell immunotherapy in treating EBV virus infection after allogenic HSCT.

Read more